2μg (R: reducing conditions)
Product Details
Product Details
Product Specification
Species | Human |
Synonyms | Proprotein Convertase Subtilisin/Kexin Type 9; Neural Apoptosis-Regulated Convertase 1; NARC-1; Proprotein Convertase 9; PC9; Subtilisin/Kexin-Like Protease PC9; PCSK9; NARC1 |
Accession | Q8NBP7 |
Amino Acid Sequence | Gln31-Gln692, with C-terminal His |
Expression System | HEK293 |
Molecular Weight |
Theoretical:72.7kDa Actual:65kDa
|
Purity | >95% by SDS-PAGE&>95% by SEC-HPLC |
Endotoxin | <1EU/μg |
Tag | His Tag |
Physical Appearance | Lyophilized Powder |
Storage Buffer |
PBS, pH7.4.
|
Reconstitution |
Reconstitute no more than 1 mg/mL according to the size in deionized water after rapid centrifugation.
|
Stability & Storage |
|
Background
Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is a secretory subtilase belonging to the proteinase K subfamily. PCSK9 is synthesized as a soluble zymogen that undergoes autocatalytic intramolecular processing in the ER , the pro domain and mature chain secrete together through noncovalent interactions. PCSK9 binds with low-density lipoprotein receptor (LDLR) and plays a major regulatory role in cholesterol homeostasis. Inhibition of PCSK9 function by preventing PCSK9/LDLR interaction is currently being explored as a means of lowering cholesterol levels. PCSK9 also binds to apolipoprotein receptor 2 (ApoER2), and play a role in the neural development.
Picture
Picture
SDS-PAGE

ELISA

Immobilized PCSK9 His Tag Protein, Human at 1 μg/mL (50 μL/well) can bind Proprotein convertase 9/PCSK9 Recombinant Rabbit mAb (SDT-424-113) (Cat. No. S0B0234) with EC50 of 2.938-3.598 ng/ ml.

